Overview
seragy - the Seed Biomarker Strategy Company. Our aim is to decode pathological protein aggregation and to reveal the molecular fingerprints behind proteopathies such as Alzheimer's, Parkinson’s, and ALS. These fingerprints reflect distinct disease subtypes and can correlate to disease progression and treatment response. Our proprietary SeRAS® (Seed Replication, Analysis and Subtyping) platform is the next generation of seed-based assays. SeRAS will go beyond the yes-or-no readouts to quantify p...See more
Website
https://seragy.com/Industry
Biotechnology Research
Company size
7 employees
Headquarters
Hannover
Founded
2022
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
EUR 12,000,000 • Funding Round
Announced on 10/14/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.